Cargando…
Efficacy and safety of calcium polystyrene sulfonate in patients with hyperkalemia and stage 3–5 non-dialysis chronic kidney disease: a single-center randomized controlled trial
OBJECTIVE: To observe the clinical efficacy and safety of the short-term administration of different doses of calcium polystyrene sulfonate in the treatment of hyperkalemia in patients with stage 3–5 non-dialysis chronic kidney disease. METHODS: A prospective, open, randomized, controlled, single-ce...
Autores principales: | Wang, Xia, Chen, Dacheng, Song, Xia, Wang, Jinquan, Zhang, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119845/ https://www.ncbi.nlm.nih.gov/pubmed/37063062 http://dx.doi.org/10.1177/03000605231167516 |
Ejemplares similares
-
Long-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients
por: Yu, Mi-Yeon, et al.
Publicado: (2017) -
Compared effectiveness of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on hyperkalemia in patients with chronic kidney disease
por: Nakayama, Takashin, et al.
Publicado: (2023) -
Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease
por: Hunt, Taylor V, et al.
Publicado: (2018) -
Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors
por: Ren, Hongru, et al.
Publicado: (2022) -
Risks and Benefits of Sodium Polystyrene Sulfonate for Hyperkalemia in Patients on Maintenance Hemodialysis
por: Nakamura, Teruko, et al.
Publicado: (2018)